ExoticRx · exoticrx.com/drugs/surovetmab
Stelfonta Adjunct
Anti-PD-L1 canine monoclonal antibody checkpoint inhibitor. Blocks PD-1/PD-L1 interaction to restore T-cell mediated anti-tumor immune response.
Investigational/conditionally approved. Immune-mediated adverse events possible. Monitor for autoimmune-like reactions. Dogs only.
Species references:All Dog (Domestic) drugs
Each ExoticRx dose rule is graded by the strength of its primary evidence — see the editorial process.
A dog/cat sample is shown here. Cited dosing for all 1 species — reptiles, birds, pocket pets, livestock, and equine — is free on the per-species pages above. Pro adds the weight-based calculator for every species.
| Species | Route | Dose | Frequency | Evidence | Source |
|---|---|---|---|---|---|
| Dog (Domestic) | IV | 5–10 mg/kg | q2-3 weeks | Weak | Papich Handbook of Veterinary Drugs, 5th Ed |
Upgrade to Pro or Student to unlock the full dose ranges and frequency for every species. The drug's mechanism, warnings, indications, and cited sources are free to read.
View PlansSource citations and evidence levels available on the live page. Reference only — verify against current literature before clinical use.